12 Mar 2018 14:07
London, 12 March 2018
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY
The Board of Georgia Healthcare Group PLC (GHG) announces the grant of deferred share salary awards by Sanne Fiduciary Services Limited acting as trustee of the Rubicon Executive Equity Compensation Trust in respect of the 2017 work year, in the form of nil-cost options over ordinary shares of GHG (GHG Shares) to persons discharging managerial responsibilities (PDMRs). The awards were made for nil consideration.
The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | Nikoloz Gamkrelidze | ||||||
2. | Reason for the notification | |||||||
a) | Position / status | CEO | ||||||
b) | Initial notification / amendment | Initial notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a)
| Name
| Georgia Healthcare Group PLC
| ||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification Code | nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
N/A | ||||||
b) | Nature of the transaction | Grant of nil-cost options in respect of deferred salary shares for the 2017 work year pursuant to the executive equity compensation plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information - Volume - Price - Total | N/A | ||||||
e) | Date of the transaction | 8 March 2018
| ||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | Irakli Gogia | ||||||
2. | Reason for the notification | |||||||
a) | Position / status | Chief Financial Officer | ||||||
b) | Initial notification / amendment | Initial notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a)
| Name
| Georgia Healthcare Group PLC
| ||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification Code | nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
N/A | ||||||
b) | Nature of the transaction | Grant of nil-cost options in respect of deferred salary shares for the 2017 work year pursuant to the executive equity compensation plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information - Volume - Price - Total | N/A | ||||||
e) | Date of the transaction | 8 March 2018
| ||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | Giorgi Mindiashvili | ||||||
2. | Reason for the notification | |||||||
a) | Position / status | Deputy CEO, Commercial | ||||||
b) | Initial notification / amendment | Initial notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a)
| Name
| Georgia Healthcare Group PLC
| ||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification Code | nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
N/A | ||||||
b) | Nature of the transaction | Grant of nil-cost options in respect of deferred salary shares for the 2017 work year pursuant to the executive equity compensation plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information - Volume - Price - Total | N/A | ||||||
e) | Date of the transaction | 8 March 2018
| ||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | David Vakhtangshvili | ||||||
2. | Reason for the notification | |||||||
a) | Position / status | Chief Risk Officer | ||||||
b) | Initial notification / amendment | Initial notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a)
| Name
| Georgia Healthcare Group PLC
| ||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification Code | nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
N/A | ||||||
b) | Nature of the transaction | Grant of nil-cost options in respect of deferred salary shares for the 2017 work year pursuant to the executive equity compensation plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information - Volume - Price - Total | N/A | ||||||
e) | Date of the transaction | 8 March 2018
| ||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||
1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||
a) | Name | Enrico Beridze | ||||||
2. | Reason for the notification | |||||||
a) | Position / status | CEO of GEPHA | ||||||
b) | Initial notification / amendment | Initial notification | ||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a)
| Name
| Georgia Healthcare Group PLC
| ||||||
b) | LEI: | 213800RJGJDDZENQER80 | ||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification Code | nil cost options over ordinary shares of £0.01 each in Georgia Healthcare Group PLC
N/A | ||||||
b) | Nature of the transaction | Grant of nil-cost options in respect of deferred salary shares for the 2017 work year pursuant to the executive equity compensation plan.
| ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information - Volume - Price - Total | N/A | ||||||
e) | Date of the transaction | 8 March 2018
| ||||||
f)
| Place of the transaction | Outside of a trading venue | ||||||
Name of authorised official of issuer responsible for making notification: Rebecca Wooldridge, Company Secretary